Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assess the Performance of Metagenomic Sequencing in the Diagnosis of STI (NGS-IST)

NCT05581160 is registered in ClinicalTrials.gov with Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba as lead sponsor.

NCT NCT05581160
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05581160 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assess the Performance of Metagenomic Sequencing in the Diagnosis of STI (NGS-IST)
Lead sponsor
Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
Phase
Not applicable
Overall status
Completed
Start date
July 11, 2022
Completion date
September 27, 2024
Enrollment
332 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

chlamydia trachomatis infection, mycoplasma genitalium infection, neisseria gonorrhoeae infection, sexually transmitted infections (not hiv or hepatitis)